Drug

TV-44749

As of the edition of 20 October 2026, TV-44749 is a drug known only by a code name: of no established status; acts on DRD2, DRD3 and DRD4 and 2 more.

Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.

The drug

Status
Status not established
Kind
Code name only
Registered trials
1, 0 stopped early
Disease areas
Mental health

US protection

No US approval on record.

With no US approval on record there are no listed US patents or exclusivities.

This is the US only.

Targets

GeneProteinUniProt
DRD2Dopamine receptor D2P14416
DRD4Dopamine receptor D4P21917
HTR2A5-hydroxytryptamine receptor 2AP28223
HTR2C5-hydroxytryptamine receptor 2CP28335
DRD3Dopamine receptor D3P35462

Registered trials

PhaseTrialsCompletedActiveStopped early
Phase 11100
All trials1

Who ran its trials

CompanyRoleYears
TevaLead sponsor of trials2024 to now